The CM-Path Biobanking Sample Quality Improvement Tool : A Guide for Improving the Quality of Tissue Collections for Biomedical Research and Clinical Trials in Cancer

Funding: The NCRI's CM-Path initiative was established in 2016 with the aim of re-invigorating academic pathology. It is funded as a collaborative venture between ten of the NCRI partner organisations: Bloodwise, Breast Cancer Now, Cancer Research UK, the Chief Scientist Office (Scotland), the Department of Health and Social Care (England), Health and Care Research Wales, Health and Social Care (Northern Ireland), the Medical Research Council, Prostate Cancer UK and Tenovus Cancer Care. These organisations did not participate in study design; collection, analysis and interpretation of data; writing the report or the decision to submit the paper for publication. Acknowledgments Thanks to the following for assisting in the scoping exercise: Joanna Baxter, Cambridge Blood and Stem Cell Bank; Chris Birkett, Human Tissue Authority; Tim Brend, Breast Cancer Now Tissue Bank, University of Leeds; Brian Clark, Novo Nordisk; Emma Lawrence, UKCRC Tissue Directory and Coordination Centre; Alex MacLellan, CRUK Tissue Group, Edinburgh; Balwir Matharoo-Ball, Nottingham Health Sciences Biobank; Bill Mathieson, NHS Grampian Biorepository; Gita Mistry Children’s Cancer and Leukaemia Group Tissue Bank; Will Navaie, Health Research Authority; Rob Oliver, Salford Royal NHS Foundation Trust; Kathleen Potter, Cancer Sciences Tissue Bank, University of Southampton; Doris Rassl, Papworth Hospital NHS Foundation Trust; Jane Steele, Human Biomaterials Resource Centre, University of Birmingham; Sarah Yeats, WISH Lab, University of Southampton. Special thanks Anne Carter for her tireless work with CCB and to staff at the following biobanks who piloted the Sample Quality Improvement Tool: Greater Glasgow & Clyde Biorepository, Leeds Breast Cancer Now Tissue Bank, Leeds Multidisciplinary Research Tissue Bank and Southampton Tissue Bank.Peer reviewedPostprin

Molecular Tools for Exploring Polyploid Genomes in Plants

Polyploidy is a very common phenomenon in the plant kingdom, where even diploid species are often described as paleopolyploids. The polyploid condition may bring about several advantages compared to the diploid state. Polyploids often show phenotypes that are not present in their diploid progenitors or exceed the range of the contributing species. Some of these traits may play a role in heterosis or could favor adaptation to new ecological niches. Advances in genomics and sequencing technology may create unprecedented opportunities for discovering and monitoring the molecular effects of polyploidization. Through this review, we provide an overview of technologies and strategies that may allow an in-depth analysis of polyploid genomes. After introducing some basic aspects on the origin and genetics of polyploids, we highlight the main tools available for genome and gene expression analysis and summarize major findings. In the last part of this review, the implications of next generation sequencing are briefly discussed. The accumulation of knowledge on polyploid formation, maintenance, and divergence at whole-genome and subgenome levels will not only help plant biologists to understand how plants have evolved and diversified, but also assist plant breeders in designing new strategies for crop improvement